Arcus Biosciences Inc logo

RCUS - Arcus Biosciences Inc News Story

$34.55 -1.7  -4.7%

Last Trade - 03/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.84bn
Enterprise Value £1.32bn
Revenue £55.6m
Position in Universe 1972nd / 6642

BRIEF-Arcus Appoints Andrew Perlman, Michael Quigley To Board Of Directors

Wed 6th January, 2021 9:32pm
Jan 6 (Reuters) - Arcus Biosciences Inc  RCUS.N :
    * ARCUS BIOSCIENCES APPOINTS BIOTECH INDUSTRY VETERAN,
ANDREW
PERLMAN, M.D., PH.D. AND GILEAD’S SVP OF RESEARCH BIOLOGY,
MICHAEL QUIGLEY, PH.D. TO ITS BOARD OF DIRECTORS

Source text for Eikon:  ID:nBw6VL404a 
Further company coverage:  RCUS.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.